Web Desc
Basic Aspects of Tumor Immunology II
Organizer(s): Nicholas P. Restifo and Nina Bhardwaj
Date: March 19 - 24, 2005
Location: Keystone Resort, Keystone, CO, USA
Supported by The Director's Fund
For important information on the coronavirus, please click here
Summary of Meeting:
The identification of a large number of tumor-associated antigens has opened up a world of possibilities for cancer immunologists. We have devised immunization strategies that enable us to boost immune responses against these antigens -- some encouraging but preliminary results have been obtained in the clinic. Most importantly, the adoptive transfer of tumor-specific T cells has emerged as an immunotherapeutic strategy that can cause solid tumors to reliably shrink. The challenge now is to gain a deeper understanding of how immune cells traffic to, interact with, and potentially destroy tumor cells. This meeting will bring together experts from academia and industry in an effort to elucidate the basic immunology that could make it possible to trigger and sustain an immune response capable of mediating the complete destruction of tumor cells.
Discounted Abstract Deadline: November 18 2004
Discounted Registration Deadline: January 19 2005
We gratefully acknowledge additional support for this conference from:
3M PharmaceuticalsXcyte Therapies, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Saturday, March 19 | 3:00PM - 7:00PM
Registration
Room: Longs Foyer


Saturday, March 19 | 6:00PM - 7:00PM
Refreshments
Room: Longs Foyer


Saturday, March 19 | 7:00PM - 9:00PM
Opening Addresses
Room: Shavano/Torreys

Speaker 1 of 2
Rafi Ahmed, Emory University School of Medicine, USA
Memory CD8 T Cell Differentiation during Acute Versus Chronic Viral Infection

Saturday, March 19 | 7:00PM - 9:00PM
Opening Addresses
Room: Shavano/Torreys

Speaker 2 of 2
Craig B. Thompson, Memorial Sloan Kettering Cancer Center, USA
Fueling an Anti-Tumor Response

Sunday, March 20 | 7:00AM - 8:00AM
Breakfast
Room: Grays/Longs


Sunday, March 20 | 8:00AM - 9:00AM
Keynote Address
Room: Shavano/Torreys

Speaker 1 of 1
Steven A. Rosenberg, NCI, National Institutes of Health, USA
Human Cancer Immunotherapy

Sunday, March 20 | 9:00AM - 9:20AM
Coffee Break
Room: Longs Foyer


Sunday, March 20 | 9:20AM - 11:00AM
Novel Cellular Immunotherapies
Room: Shavano/Torreys

Speaker 1 of 3
Richard J. O'Reilly, Memorial Sloan-Kettering Cancer Center, USA
Adoptive Transfer of Donor-Derived Antigen0Specific T cells for the Treatment of Hematologic Malignancies Following Allogeneic Hematopoietic Cell Transplants

Sunday, March 20 | 9:20AM - 11:00AM
Novel Cellular Immunotherapies
Room: Shavano/Torreys

Speaker 2 of 3
* Gary J. Nabel, Sanofi, USA
Building Better Cancer Vaccines: Lessons from HIV

Sunday, March 20 | 9:20AM - 11:00AM
Novel Cellular Immunotherapies
Room: Shavano/Torreys

Speaker 3 of 3
Philip D. Greenberg, University of Washington, USA
Cellular and Molecular Engineering of T Cell Responses to Promote Eradication of Tumors

Sunday, March 20 | 11:00AM - 1:00PM
Poster Setup
Room: Grays/Longs


Sunday, March 20 | 1:00PM - 10:00PM
Poster Viewing
Room: Grays/Longs


Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1A: Novel Clinical Approaches
Room: Shavano

Speaker 1 of 7
Jeffrey Weber, New York University, USA
Novel Adjuvants Approaches for Melanoma Vaccines

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1A: Novel Clinical Approaches
Room: Shavano

Speaker 2 of 7
A. Karolina Palucka, The Jackson Laboratory for Genomic Medicine, USA
Dendritic Cell Vaccines in Cancer

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1A: Novel Clinical Approaches
Room: Shavano

Speaker 3 of 7
Thomas Gajewski, University of Chicago, USA
Understanding and Modifying the Melanoma Tumor Microenvironment

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1A: Novel Clinical Approaches
Room: Shavano

Speaker 4 of 7
Craig L. Slingluff, University of Virginia, USA
Multipeptide Vaccines for Melanoma - Targeting CD8 and CD4 Cells

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1A: Novel Clinical Approaches
Room: Shavano

Speaker 5 of 7
Lisa H. Butterfield, University of Pittsburgh, USA
AFP Specific T cell Responses in HCC

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1A: Novel Clinical Approaches
Room: Shavano

Speaker 6 of 7
Victor Appay, INSERM U1135 - CIMI, France
The Physiological Role of Cytotoxic CD4(+) T-Cells: The Holy Grail?

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1A: Novel Clinical Approaches
Room: Shavano

Speaker 7 of 7
Adam J. Adler, University of Connecticut Health Center, USA
In vivo Cyclophosphamide and IL-2 Treatment Impedes Self-Antigen-Induced Effector CD4 Cell Tolerization: Implications for Adoptive Immunotherapy

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1B: New Findings in the Mouse
Room: Torreys

Speaker 1 of 7
Bruce W. Robinson, University of Western Australia, Australia
The Biological Significance of Cross-Presentation to Tumor Immunology

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1B: New Findings in the Mouse
Room: Torreys

Speaker 2 of 7
Federica Cavallo, University of Turin, Italy
Induction of a Long-Term Anti-Tumor Immune Memory in Her-2 Transgenic Mice

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1B: New Findings in the Mouse
Room: Torreys

Speaker 3 of 7
Ofir Goldberger, Fluidigm Corporation, USA
T Cell Precursor Frequency Alone is Insufficient to Trigger Tumor Regression

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1B: New Findings in the Mouse
Room: Torreys

Speaker 4 of 7
Catherine Sautes-Fridman, Cordeliers Research Center, INSERM U872, France
The Role of FcgR in Tumor Immunity and Tumor Escape

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1B: New Findings in the Mouse
Room: Torreys

Speaker 5 of 7
* Frédéric Lévy, Ludwig Institute for Cancer Research, Switzerland
Immunoproteasome Limits the Induction of Anti-Melan-A T Cell Response in vivo

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1B: New Findings in the Mouse
Room: Torreys

Speaker 6 of 7
Eli Young, Genitrix, LLC, USA
Opsonokines: Breaking the Immunogenicity Barrier

Sunday, March 20 | 2:00PM - 4:30PM
Afternoon Session 1B: New Findings in the Mouse
Room: Torreys

Speaker 7 of 7
Wilfred A. Jefferies, University of British Columbia, Canada
The Restoration TAP Expression in Carcinomas Increases Tumor Specific
Immune Responses and Survival


Sunday, March 20 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Longs Foyer


Sunday, March 20 | 5:00PM - 7:00PM
New Strategies for Cancer Immunotherapy I
Room: Shavano/Torreys

Speaker 1 of 3
* Cliona M. Rooney, Baylor College of Medicine, USA
Improving Survival, Expansion And Persistence Of Adoptively-Transferred Tumor-Specific CTLs.

Sunday, March 20 | 5:00PM - 7:00PM
New Strategies for Cancer Immunotherapy I
Room: Shavano/Torreys

Speaker 2 of 3
Carl H. June, University of Pennsylvania, USA
Rebuilding Immunity after Chrmotherapy

Sunday, March 20 | 5:00PM - 7:00PM
New Strategies for Cancer Immunotherapy I
Room: Shavano/Torreys

Speaker 3 of 3
Ronald Levy, Stanford University, USA
Current Immunotherapies for Hematologic Malignancies

Sunday, March 20 | 7:00PM - 8:00PM
Social Hour
Room: Grays/Longs


Sunday, March 20 | 7:30PM - 10:00PM
Poster Session 1
Room: Grays/Longs


Monday, March 21 | 7:00AM - 8:00AM
Breakfast
Room: Grays/Longs


Monday, March 21 | 8:00AM - 9:00AM
New Strategies for Cancer Immunotherapy II
Room: Shavano/Torreys

Speaker 1 of 1
Nicholas P. Restifo, Lyell, USA
Translating New Basic Immunology into Human Immunotherapies

Monday, March 21 | 9:00AM - 9:20AM
Coffee Break
Room: Longs Foyer


Monday, March 21 | 9:20AM - 11:00AM
Innate Immunity and Autoimmunity
Room: Shavano/Torreys

Speaker 1 of 3
Caetano Reis e Sousa, Francis Crick Institute, UK
Learning from Viruses: How to Activate Dendritic Cells for Anti-Tumour Immunity

Monday, March 21 | 9:20AM - 11:00AM
Innate Immunity and Autoimmunity
Room: Shavano/Torreys

Speaker 2 of 3
* Pamela S. Ohashi, Princess Margaret Cancer Centre, Canada
Manipulating Tolerance and Immune Surveillance

Monday, March 21 | 9:20AM - 11:00AM
Innate Immunity and Autoimmunity
Room: Shavano/Torreys

Speaker 3 of 3
Alexandre Corthay, University of Oslo and Rikshospitalet University Hospital, Norway
Primary Antitumor Immune Response Mediated by CD4+ T Cells

Monday, March 21 | 11:00AM - 12:00PM
Poster Setup
Room: Grays/Longs


Monday, March 21 | 11:00AM - 12:00PM
Lunch
Room: Grays/Longs


Monday, March 21 | 11:30AM - 2:00PM
Poster Session 2
Room: Grays/Longs


Monday, March 21 | 2:00PM - 4:30PM
Afternoon Session 2A: Toll-Like Receptors/ Death, Danger and
Dendritic Cells
Room: Shavano

Speaker 1 of 7
* Arthur M. Krieg, Checkmate Pharmaceuticals, USA
Activating Innate and Adaptive Immunity by in vivo Activation of TLR9 with CpG Oligos

Monday, March 21 | 2:00PM - 4:30PM
Afternoon Session 2A: Toll-Like Receptors/ Death, Danger and
Dendritic Cells
Room: Shavano

Speaker 2 of 7
Charles G. Drake, Columbia University, USA
CD4+ T Cell Tolerance to Protstate Cancer

Monday, March 21 | 2:00PM - 4:30PM
Afternoon Session 2A: Toll-Like Receptors/ Death, Danger and
Dendritic Cells
Room: Shavano

Speaker 3 of 7
Vincenzo Cerundolo, University of Oxford, UK
The Role of NKT Cells in Assisting Priming of Antigen Specific T Cells

Monday, March 21 | 2:00PM - 4:30PM
Afternoon Session 2A: Toll-Like Receptors/ Death, Danger and
Dendritic Cells
Room: Shavano

Speaker 4 of 7
Jonathan P. Schneck, Johns Hopkins School of Medicine, USA
Develpment of Artificial Antigen Presenting Complexes, a APC, for Adaptive Immunotherapy

Monday, March 21 | 2:00PM - 4:30PM
Afternoon Session 2A: Toll-Like Receptors/ Death, Danger and
Dendritic Cells
Room: Shavano

Speaker 5 of 7
Matteo Maria Bellone, San Raffaele Scientific Institute, Italy
Peripheral T Cell Tolerance Occurs Early during Prostate Cancer Development and Can be Rescued by Dendritic Cell Immunization

Monday, March 21 | 2:00PM - 4:30PM
Afternoon Session 2A: Toll-Like Receptors/ Death, Danger and
Dendritic Cells
Room: Shavano

Speaker 6 of 7
Bertrand Huard, Centre Medical Universitaire, Switzerland
Cross-Presentation of a B16 Neo-Antigen Induces the Accumulation of Anergic CD8+ T Cells

Monday, March 21 | 2:00PM - 4:30PM
Afternoon Session 2A: Toll-Like Receptors/ Death, Danger and
Dendritic Cells
Room: Shavano

Speaker 7 of 7
Lloyd M. Stoolman, University of Michigan, USA
Vascular Adhesive Interactions Control Clinical Responses during Adoptive Immunotherapy of Murine Cancer

Monday, March 21 | 2:00PM - 3:25PM
Afternoon Session 2B: Editor's Roundtable
Room: Torreys

Speaker 1 of 4
* Alison Farrell, Springer Nature, USA

Monday, March 21 | 2:00PM - 3:25PM
Afternoon Session 2B: Editor's Roundtable
Room: Torreys

Speaker 2 of 4
* Stephen James Simpson, Arthritis Research UK, UK

Monday, March 21 | 2:00PM - 3:25PM
Afternoon Session 2B: Editor's Roundtable
Room: Torreys

Speaker 3 of 4
Peter T. Lee, Immunity, Cell Press, USA

Monday, March 21 | 2:00PM - 3:25PM
Afternoon Session 2B: Editor's Roundtable
Room: Torreys

Speaker 4 of 4
Ushma Savla Neill, Journal of Clinical Investigation & Molecular Metabolism, USA

Monday, March 21 | 3:30PM - 4:30PM
Afternoon Session 2B: Altered States: T Cells in Immunothera
py
Room: Torreys

Speaker 1 of 3
* Daniel E. Speiser, Ludwig Center, University of Lausanne, Switzerland
Distinguishing Protective from Non-Protective T Cell Responses

Monday, March 21 | 3:30PM - 4:30PM
Afternoon Session 2B: Altered States: T Cells in Immunothera
py
Room: Torreys

Speaker 2 of 3
Nathalie Rufer, Swiss Institute for Experimental Cancer Research, Switzerland
Ex vivo Tracking of Dominant Monoclonal T-Cell Responses

Monday, March 21 | 3:30PM - 4:30PM
Afternoon Session 2B: Altered States: T Cells in Immunothera
py
Room: Torreys

Speaker 3 of 3
Bernard A. Fox, Earle A Chiles Research Institute, USA
The Uses and Mechanisms of Lymphodepletion

Monday, March 21 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Longs Foyer


Monday, March 21 | 5:00PM - 7:00PM
Dendritic Cells
Room: Shavano/Torreys

Speaker 1 of 4
* Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, USA
Crosspresentation of Cell Associated Antigens by Dendritic Cells

Monday, March 21 | 5:00PM - 7:00PM
Dendritic Cells
Room: Shavano/Torreys

Speaker 2 of 4
Yong-Jun Liu, Sanofi, USA
TSLP and IL7

Monday, March 21 | 5:00PM - 7:00PM
Dendritic Cells
Room: Shavano/Torreys

Speaker 3 of 4
Michael L. Dustin, University of Oxford, UK
The immunological synapse

Monday, March 21 | 5:00PM - 7:00PM
Dendritic Cells
Room: Shavano/Torreys

Speaker 4 of 4
Alex Y.C. Huang, Case Western Reserve University School of Medicine, USA
Short Talk: Imaging Immune Cell Function in situ

Tuesday, March 22 | 7:00AM - 8:00AM
Breakfast
Room: Grays/Longs


Tuesday, March 22 | 8:00AM - 9:00AM
Autoimmunity

Speaker 1 of 1
* Jeffrey A. Bluestone, University of California, San Francisco, USA
Autoimmunity and Cancer Immunity: A Balancing Act

Tuesday, March 22 | 9:20AM - 11:00AM
Maintenance of the Anti-Tumor Immune Response
Room: Shavano/Torreys

Speaker 1 of 4
Leo Lefrançois, University of Connecticut Health Center, USA
Regulation of DC8+ T Cell Memory Lineage Development

Tuesday, March 22 | 9:20AM - 11:00AM
Maintenance of the Anti-Tumor Immune Response
Room: Shavano/Torreys

Speaker 2 of 4
Lieping Chen, Yale University, USA
B7-H1 in Cancer Immune Evasion

Tuesday, March 22 | 9:20AM - 11:00AM
Maintenance of the Anti-Tumor Immune Response
Room: Shavano/Torreys

Speaker 3 of 4
* Patrick Hwu, University of Texas MD Anderson Cancer Center, USA
The Use of Dendritic Cells to Enhance the Effectiveness of Adoptively Transferred T-Cells

Tuesday, March 22 | 9:20AM - 11:00AM
Maintenance of the Anti-Tumor Immune Response
Room: Shavano/Torreys

Speaker 4 of 4
Samuel C. Silverstein, Columbia University College of Physicians & Surgeons, USA

Tuesday, March 22 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Foyer


Tuesday, March 22 | 11:00AM - 1:00PM
Poster Setup
Room: Grays/Longs


Tuesday, March 22 | 1:00PM - 10:00PM
Poster Viewing
Room: Grays/Longs


Tuesday, March 22 | 2:00PM - 3:00PM
Afternoon Session 3: Special Lecture
Room: Shavano

Speaker 1 of 1
Alexander Y. Rudensky, HHMI/Memorial Sloan Kettering Cancer Center, USA
Genetic Mechanism of Dominant Tolerance

Tuesday, March 22 | 3:00PM - 4:30PM
Afternoon Session 3: T Regulatory Cells
Room: Shavano

Speaker 1 of 5
* Ciriaco A. Piccirillo, McGill University, Canada
Control of Immune Responses by Naturally-Occurring CD4+CD25+ Regulatory Lymphocytes: Lessons from in vitro and in vivo Models

Tuesday, March 22 | 3:00PM - 4:30PM
Afternoon Session 3: T Regulatory Cells
Room: Shavano

Speaker 2 of 5
* Rienk Offringa, Genentech Inc., USA
Analysis of CD4 T Cell Immunity Against HPV16 in Patients with Cervical Neoplasia and Healthy Subjects

Tuesday, March 22 | 3:00PM - 4:30PM
Afternoon Session 3: T Regulatory Cells
Room: Shavano

Speaker 3 of 5
Awen M. Gallimore, Cardiff University, UK
The Effect of CD4+CD25+ Regulatory T Cells on Anti-Tumor Immune Responses in Mice and Men

Tuesday, March 22 | 3:00PM - 4:30PM
Afternoon Session 3: T Regulatory Cells
Room: Shavano

Speaker 4 of 5
Johannes W. Vieweg, University of Florida, USA
Disruption of Regulatory Pathways to Enhance the Efficacy of Cancer Vaccines

Tuesday, March 22 | 3:00PM - 4:30PM
Afternoon Session 3: T Regulatory Cells
Room: Shavano

Speaker 5 of 5
Weiping Zou, University of Michigan, USA
Regulatory T Cells and Preliminary Results in a Clinical Trial with Ontak Treated Cancer Patients

Tuesday, March 22 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Longs Foyer


Tuesday, March 22 | 5:00PM - 7:00PM
T Regulatory Cells
Room: Shavano/Torreys

Speaker 1 of 4
* Abul K. Abbas, University of California, San Francisco, USA
The Control of T-Cell Activation vs Tolerance

Tuesday, March 22 | 5:00PM - 7:00PM
T Regulatory Cells
Room: Shavano/Torreys

Speaker 2 of 4
Shimon Sakaguchi, Osaka University, Japan
Control of Immune Response by Foxp3+ CD25+ CD4 Tr Cells

Tuesday, March 22 | 5:00PM - 7:00PM
T Regulatory Cells
Room: Shavano/Torreys

Speaker 3 of 4
Harald von Boehmer, Harvard Medical School, USA
Dynamics of Suppressor T Cells: in vivo veritas

Tuesday, March 22 | 5:00PM - 7:00PM
T Regulatory Cells
Room: Shavano/Torreys

Speaker 4 of 4
Rong-Fu Wang, Baylor College of Medicine, USA
Short Talk: Regulatory T Cells in Prostate Cancer

Tuesday, March 22 | 7:00PM - 8:00PM
Social Hour
Room: Grays/Longs


Tuesday, March 22 | 7:30PM - 10:00PM
Poster Session 3
Room: Grays/Longs


Wednesday, March 23 | 7:00AM - 8:00AM
Breakfast
Room: Grays/Longs


Wednesday, March 23 | 8:00AM - 9:00AM
Concluding Address
Room: Shavano/Torreys

Speaker 1 of 1
Richard A. Flavell, HHMI/Yale University School of Medicine, USA
Potential Molecular and Cellular Components of a Productive Anti-Tumor
Immune Response: A Summing Up


Wednesday, March 23 | 9:00AM - 9:20AM
Coffee Break
Room: Longs Foyer


Wednesday, March 23 | 9:20AM - 11:00AM
Bench-to-Bedside and Back Again
Room: Shavano/Torreys

Speaker 1 of 3
Drew M. Pardoll, Johns Hopkins University School of Medicine, USA
New Strategies for Cancer Immunotherapy

Wednesday, March 23 | 9:20AM - 11:00AM
Bench-to-Bedside and Back Again
Room: Shavano/Torreys

Speaker 2 of 3
Pedro Romero, University of Lausanne, Switzerland
Molecularly Defined Melanoma Vaccines

Wednesday, March 23 | 9:20AM - 11:00AM
Bench-to-Bedside and Back Again
Room: Shavano/Torreys

Speaker 3 of 3
* Stanley R. Riddell, Fred Hutchinson Cancer Research Center, University of Washington, USA
Allogenric Marrow Translantation Immunotherapy for Hematologic Malignacies

Wednesday, March 23 | 2:00PM - 3:00PM
Afternoon Session 4A: Special Lecture
Room: Shavano

Speaker 1 of 1
Lorenzo Moretta, University of Genova, Italy
Human NK Cells: Their Receptors and Functional Interactions

Wednesday, March 23 | 2:00PM - 4:30PM
Afternoon Session 4B: Novel Reagents
Room: Torreys

Speaker 1 of 7
* Olivera J. Finn, University of Pittsburgh School of Medicine, USA
Tumor Antigen MUC1-Based Reagents for Gene Therapy and Immunotherapy of Cancer

Wednesday, March 23 | 2:00PM - 4:30PM
Afternoon Session 4B: Novel Reagents
Room: Torreys

Speaker 2 of 7
Zelig Eshhar, Weizmann Institute of Science, Israel
Adoptive Cellular Immunotherapy of Prostate and Breast Cancer Using T-Bodies

Wednesday, March 23 | 2:00PM - 4:30PM
Afternoon Session 4B: Novel Reagents
Room: Torreys

Speaker 3 of 7
Suzanne Ostrand-Rosenberg, University of Maryland, USA
Reversal of Tumor-Induced Immune Suppression: Complex Interplay between Activated T Cells and M1 Macrophages

Wednesday, March 23 | 2:00PM - 4:30PM
Afternoon Session 4B: Novel Reagents
Room: Torreys

Speaker 4 of 7
Dapeng Zhou, MD Anderson Cancer Center, USA
The Identity of a Natural NKT Cell Ligand: Implications for Cancer Immunotherapy

Wednesday, March 23 | 2:00PM - 4:30PM
Afternoon Session 4B: Novel Reagents
Room: Torreys

Speaker 5 of 7
Juergen Kuball, University of Mainz, Germany
Redirection of the Specificity of Human Tumor-Reactive CD4(+) and CD8(+) T Cells with a High-Affinity TCR

Wednesday, March 23 | 2:00PM - 4:30PM
Afternoon Session 4B: Novel Reagents
Room: Torreys

Speaker 6 of 7
Fred J. Ramsdell, Parker Institute for Cancer Immunotherapy, USA
Mechanisms of IL-21-Mediated Tumor Rejection

Wednesday, March 23 | 2:00PM - 4:30PM
Afternoon Session 4B: Novel Reagents
Room: Torreys

Speaker 7 of 7
* Jay A. Berzofsky, NCI, National Institutes of Health, USA
Mechanism of Protection Against Breast Cancers in HER-2/neu Transgenic Mice by HER-2/neu Adenoviral Vaccine

Wednesday, March 23 | 3:00PM - 4:30PM
Afternoon Session 4A: Tumor Destruction vs. Tumor Escape
Room: Shavano

Speaker 1 of 4
Yang-Xin Fu, University of Texas Southwestern Medical Center, USA
Changing the Battlefield: Altering Immune Responses inside Tumor

Wednesday, March 23 | 3:00PM - 4:30PM
Afternoon Session 4A: Tumor Destruction vs. Tumor Escape
Room: Shavano

Speaker 2 of 4
* Richard G. Vile, Mayo Clinic, USA
Inducing Autoimmune T Cell Responses to Treat Melanoma

Wednesday, March 23 | 3:00PM - 4:30PM
Afternoon Session 4A: Tumor Destruction vs. Tumor Escape
Room: Shavano

Speaker 3 of 4
Michael Caligiuri, Ohio State University, USA
IL-15

Wednesday, March 23 | 3:00PM - 4:30PM
Afternoon Session 4A: Tumor Destruction vs. Tumor Escape
Room: Shavano

Speaker 4 of 4
Barbara Seliger, Martin Luther University, Germany
Molecular Mechanisms of the Deficient MHC Class I Antigen Processing in Tumors

Wednesday, March 23 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Longs Foyer


Wednesday, March 23 | 5:00PM - 7:00PM
Cytokines and Chemokines
Room: Shavano/Torreys

Speaker 1 of 3
Charles D. Surh, La Jolla Institute for Allergy and Immunology, USA
Key Cytokines in Lymphocyte Homeostasis

Wednesday, March 23 | 5:00PM - 7:00PM
Cytokines and Chemokines
Room: Shavano/Torreys

Speaker 2 of 3
Warren J. Leonard, National Institutes of Health, USA
IL-21

Wednesday, March 23 | 5:00PM - 7:00PM
Cytokines and Chemokines
Room: Shavano/Torreys

Speaker 3 of 3
* Crystal L. Mackall, Stanford University, USA
Incorporating IL-7 into Immunotherapy for Cancer

Wednesday, March 23 | 7:00PM - 8:00PM
Social Hour
Room: Grays/Longs


Wednesday, March 23 | 8:00PM - 11:00PM
Entertainment
Room: Grays/Longs


Wednesday, March 23 | 8:00PM - 11:00PM
Cash Bar
Room: Grays/Longs


Thursday, March 24 | 10:21AM - 10:21AM
Departure


*Session Chair
†Invited, not yet responded.